These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30762589)

  • 21. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic monitoring of patients prescribed second-generation antipsychotics.
    Dhamane AD; Martin BC; Brixner DI; Hudson TJ; Said Q
    J Psychiatr Pract; 2013 Sep; 19(5):360-74. PubMed ID: 24042242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics.
    Edelsohn GA; Parthasarathy M; Terhorst L; Karpov IO; Schuster J
    J Manag Care Spec Pharm; 2015 Sep; 21(9):769-77, 777a-777cc. PubMed ID: 26308224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics.
    Coughlin M; Goldie CL; Tregunno D; Tranmer J; Kanellos-Sutton M; Khalid-Khan S
    Int J Ment Health Nurs; 2018 Jun; 27(3):1188-1198. PubMed ID: 29205757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to Recommended Metabolic Monitoring of Children and Adolescents Taking Second-Generation Antipsychotics.
    Sanyal S; Calarge C; Rowan PJ; Aparasu RR; Abughosh S; Sisley S; Chen H
    Psychiatr Serv; 2024 Apr; 75(4):342-348. PubMed ID: 37789728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents.
    Sanyal S; Calarge CA; Rowan PJ; Aparasu RR; Abughosh S; Chen H
    J Psychiatr Res; 2023 Sep; 165():170-173. PubMed ID: 37506412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
    Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
    Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic Monitoring Rates of Youth Treated with Second-Generation Antipsychotics in Usual Care: Results of a Large US National Commercial Health Plan.
    Hayden JD; Horter L; Parsons T; Ruble M; Townsend S; Klein CC; Duran RP; Welge JA; Crystal S; Patel NC; Correll CU; DelBello MP
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):119-122. PubMed ID: 31851522
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability.
    Teeluckdharry S; Sharma S; O'Rourke E; Tharian P; Gondalekar A; Nainar F; Roy M
    J Intellect Disabil; 2013 Sep; 17(3):223-35. PubMed ID: 23801356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of Metabolic Adverse Effects Associated With Atypical Antipsychotics Use in an Outpatient Psychiatric Clinic.
    Pereira L; Budovich A; Claudio-Saez M
    J Pharm Pract; 2019 Aug; 32(4):388-393. PubMed ID: 29334810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet and cardiometabolic side effects in children treated with second-generation antipsychotics.
    Barker MK; Sable CM; Montgomery SE; Chow L; Green TJ; Panagiotopoulos C; Devlin AM
    Clin Nutr ESPEN; 2018 Feb; 23():205-211. PubMed ID: 29460800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic screening in children receiving antipsychotic drug treatment.
    Morrato EH; Nicol GE; Maahs D; Druss BG; Hartung DM; Valuck RJ; Campagna E; Newcomer JW
    Arch Pediatr Adolesc Med; 2010 Apr; 164(4):344-51. PubMed ID: 20368487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin for weight control in pediatric patients on atypical antipsychotic medication.
    Shin L; Bregman H; Breeze JL; Noyes N; Frazier JA
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):275-9. PubMed ID: 19519262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of abnormal metabolic parameters and weight gain induced by atypical antipsychotics in elderly patients with dementia.
    Mathys M; Blaszczyk A; Busti A
    Consult Pharm; 2009 Mar; 24(3):201-9. PubMed ID: 19555135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to guidelines for glucose assessment in starting second-generation antipsychotics.
    Raebel MA; Penfold R; McMahon AW; Reichman M; Shetterly S; Goodrich G; Andrade S; Correll CU; Gerhard T
    Pediatrics; 2014 Nov; 134(5):e1308-14. PubMed ID: 25287454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
    Meyer JM
    J Clin Psychiatry; 2002 May; 63(5):425-33. PubMed ID: 12019668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès?
    Jazi S; Ben-Amor L; Abadie P; Menard ML; Choquette R; Berthiaume C; Mottron L; Ilies D
    Can J Psychiatry; 2021 Jul; 66(7):645-656. PubMed ID: 33243011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics.
    Panagiotopoulos C; Ronsley R; Kuzeljevic B; Davidson J
    Can J Psychiatry; 2012 Jan; 57(1):34-44. PubMed ID: 22296966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provider Specialty and Receipt of Metabolic Monitoring for Children Taking Antipsychotics.
    Shenkman E; Thompson L; Bussing R; Forrest CB; Woodard J; Sun Y; Mack J; Mistry KB; Gurka MJ
    Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33262265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.